Kalinski, Pawel, MD, PhD
1 clinical trials · Sponsor
◉ Watch Kalinski, Pawel, MD, PhD
| Record | Firm | Date |
|---|---|---|
| Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer (NCT07634094) | Kalinski, Pawel, MD, PhD | 2026-08-01 |
Track Kalinski, Pawel, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.